Renaissance Technologies LLC cut its position in Exponent, Inc. (NASDAQ:EXPO) by 18.7% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 587,600 shares of the business services provider’s stock after selling 135,300 shares during the quarter. Renaissance Technologies LLC owned approximately 1.13% of Exponent worth $34,398,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in EXPO. Bremer Bank National Association bought a new position in Exponent in the first quarter worth about $55,000. NN Investment Partners Holdings N.V. bought a new position in Exponent in the second quarter worth about $91,000. Atria Investments LLC bought a new position in Exponent in the second quarter worth about $115,000. Cim LLC bought a new position in Exponent in the second quarter worth about $200,000. Finally, Coldstream Capital Management Inc. bought a new position in Exponent in the first quarter worth about $210,000. Institutional investors and hedge funds own 88.11% of the company’s stock.
In related news, insider John Pye sold 3,000 shares of the stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $70.31, for a total value of $210,930.00. Following the transaction, the insider now owns 25,747 shares in the company, valued at approximately $1,810,271.57. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Richard L. Schlenker, Jr. sold 22,243 shares of the stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $70.57, for a total transaction of $1,569,688.51. Following the completion of the transaction, the chief financial officer now owns 247,118 shares in the company, valued at approximately $17,439,117.26. The disclosure for this sale can be found here. In the last quarter, insiders sold 102,773 shares of company stock worth $7,227,536. 2.30% of the stock is owned by corporate insiders.
Shares of EXPO traded up $0.27 during mid-day trading on Friday, hitting $70.18. 4,178 shares of the company traded hands, compared to its average volume of 188,160. Exponent, Inc. has a 1-year low of $44.44 and a 1-year high of $72.15. The company has a quick ratio of 3.60, a current ratio of 3.60 and a debt-to-equity ratio of 0.05. The company has a market capitalization of $3.57 billion, a PE ratio of 56.59 and a beta of 0.43. The business has a 50 day moving average of $69.57 and a 200 day moving average of $60.56.
Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Thursday, July 18th. The business services provider reported $0.39 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.33 by $0.06. Exponent had a net margin of 19.64% and a return on equity of 23.44%. The firm had revenue of $106.50 million for the quarter, compared to the consensus estimate of $95.77 million. During the same quarter in the prior year, the company posted $0.34 earnings per share. The company’s revenue for the quarter was up 11.4% compared to the same quarter last year. As a group, research analysts expect that Exponent, Inc. will post 1.47 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Friday, September 6th will be issued a $0.16 dividend. The ex-dividend date is Thursday, September 5th. This represents a $0.64 annualized dividend and a yield of 0.91%. Exponent’s dividend payout ratio (DPR) is presently 51.20%.
A number of brokerages have commented on EXPO. ValuEngine upgraded shares of Exponent from a “sell” rating to a “hold” rating in a report on Wednesday, September 4th. BidaskClub downgraded shares of Exponent from a “buy” rating to a “hold” rating in a report on Tuesday. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “strong-buy” rating and set a $76.00 price objective on the stock in a report on Monday, July 22nd. DA Davidson assumed coverage on shares of Exponent in a report on Wednesday, August 28th. They set a “neutral” rating on the stock. Finally, SunTrust Banks set a $70.00 price objective on shares of Exponent and gave the company a “buy” rating in a report on Friday, July 19th. Four equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. Exponent has an average rating of “Buy” and a consensus target price of $73.00.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Recommended Story: How to read a candlestick chart
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.